Results 101 to 110 of about 4,001 (193)
Alpha-tubulin co-localizes with dysferlin.
GFP-dysferlin was expressed in C2C12 myoblasts and myotubes. The localization of GFP-dysferlin was compared to that of endogenous alpha-tubulin stained with anti-alpha-tubulin antibody by confocal microscopy.
Bilal A. Azakir (192892) +3 more
core +1 more source
Progressive limb and girdle muscle atrophy leading to loss of ambulation is a hallmark of dysferlinopathies, which include limb-girdle muscular dystrophy type 2B and Miyoshi myopathy.
Stephanie L. Sellers +9 more
doaj +1 more source
Mutations in the DYSF gene, encoding the protein dysferlin, lead to several forms of muscular dystrophy. In healthy skeletal muscle, dysferlin concentrates in the transverse tubules and is involved in repairing the sarcolemma and stabilizing Ca2 ...
Joaquin Muriel +10 more
doaj +1 more source
Dysferlin-deficient muscular dystrophy features amyloidosis
Objective: Dysferlin (DYSF) gene mutations cause limb girdle muscular dystrophy type 2B and Miyoshi\u27s myopathy. The consequences of DYSF mutations on protein structure are poorly understood.
Bushby K +9 more
core +5 more sources
Dysferlin deficiency alters lipid metabolism and remodels the skeletal muscle lipidome in mice
Defects in the gene coding for dysferlin, a membrane-associated protein, affect many tissues, including skeletal muscles, with a resultant myopathy called dysferlinopathy.
Vanessa R. Haynes +6 more
doaj +1 more source
Mapping the determinants of dysferlin dimerization.
(A) Dependence of FRET efficiencies on the protein expression levels of C2A to C2D domains of dysferlin. Hyperbolic fitting showed that the C2B (red), C2C (green) and C2D (purple) domains of dysferlin all mediate the self-interaction.
Sandeep Pallikkuth (339527) +5 more
core +1 more source
There is no cure or beneficial management option for Limb-Girdle muscular dystrophy (MD) type 2B (LGMD2B). Losartan, a blood pressure (BP) lowering angiotensin II (AngII) receptor type 1 (ATR1) blocker (ARB) with unique anti-transforming growth factor-β (
Zoe White +6 more
doaj +1 more source
Immunoblot validation and characterization of dysferlin.
A) Western blot of several proteins that were increased or decreased in DBA patients including dysferlin (DYSF), gamma-adducin (ADD3), major vault protein (MVP), serine palmitoyltransferase 1 and 2 (SPTLC1 and SPTLC2), HLA-ABC, and intercellular adhesion
Monica Bessler (508914) +5 more
core +1 more source

